Skip to main content
SpringerLink
Log in

Lipide

  • Chapter
Diabetes und Herz

  • 723 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Abbott WG, Lillioja S, Young AA et al (1987) Relationship between plasma lipoprotein concentration and insulin action in an obese hyperinsulinemic population. Diabetes 36:897–904

    PubMed  Google Scholar 

  2. Assmann G, Schulte H (1989) Diabetes mellitus and hypertension in the elderly. Concomitant hyperlipidemia and coronary heart disease risk. Am J Cardiol 63:33H–37H

    Article  PubMed  Google Scholar 

  3. Assmann G, Schulte H (1992) Relation of high-density-lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol 70:733–737

    Article  PubMed  Google Scholar 

  4. Berneis KK, Krauss RM (2002) Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 43:1363–1379

    Article  PubMed  Google Scholar 

  5. Betteridge DJ (2000) Diabetic dyslipidaemia. Diab, Obesity and Metabol 2(Suppl 1):531–536

    Google Scholar 

  6. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB (1986) Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA 256:2835–2838

    PubMed  Google Scholar 

  7. Chiasson JL, Josse RG, Gomis R et al (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359:2072–2077

    Article  PubMed  Google Scholar 

  8. Chiasson JL, Josse RG, Gomis R et al (2002) Prevention of Type 2 Diabetes Mellitus. In: Waldhäusl W (ed) Diabetologia — Abstract Volume of the 38th ann Meeting. Springer, Heidelberg, p A104

    Google Scholar 

  9. Cook CB, Erdman DM, Ryan GJ et al (2000) The pattern of dyslipidemia among urban african-americans with type 2 diabetes. Diabetes Care 23:319–324

    PubMed  Google Scholar 

  10. Csaszar A, Dieplinger H, Sandholzer C et al (1993) Plasma lipoprotein(a) concentration and phenotypes in diabetes mellitus. Diabetologia 36:47–51

    Article  PubMed  Google Scholar 

  11. Cullen P, Eckardstein A, Souris S et al (1999) Dyslipidaemia and cardiovascular risk in diabetes. Diab, Obesity and Metabol 1:189–198

    Google Scholar 

  12. DECODE Study group on behalf of the European Diabetes Epidemiology study group (1999) Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria. Lancet 354:617–621

    Google Scholar 

  13. Deslypere JP, Jackson G (1998) A lipid hypothesis: prediction, observation and the triglycerides/HDL gap. Cur Med Res Op 14:65–78

    Google Scholar 

  14. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr, for the AFCAPS/TexCAPS Research group (1998) Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of the AFCAPS/TexCAPS. JAMA 279:1615–1622

    Article  PubMed  Google Scholar 

  15. Dunn FL, Carroll P, Vlachokosta F et al (1985) Effect of treatment with the artificial beta-cell on triglyceride metabolism in type I diabetes mellitus. Diabetes 34(Suppl 1):86A

    Google Scholar 

  16. Dunn FL, Carroll PB, Beltz WF (1987) Treatment with artificial beta-cell decreases very low density lipoprotein triglyceride synthesis in type I diabetes. Diabetes 3:661–666

    Google Scholar 

  17. Eisenberg S (1998) Very low density lipoprotein metabolism. Prog Biochem Pharmacol 15:139–165

    Google Scholar 

  18. Elkeles RS, Diamond JR, Poulter C, Dhanjil S, Nicolaides AN, Mahmood S, Richmond W, Mather H, Sharp P, Feher MD (1998) Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary’s, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) study. Diabetes Care 21:641–648

    PubMed  Google Scholar 

  19. Fischer S, Hanefeld M, Schwanebeck U et al (1995) Hyperlipidämien bei neu diagnostizierten Typ-2-Diabetikern — Prävalenz, Verlauf und Behandlungsergebnisse. Diab Stoffw 4:349–356

    Google Scholar 

  20. Fontbonne A, Eschwege E, Cambien F et al (1989) Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 32:300–304

    Article  PubMed  Google Scholar 

  21. Fontbonne A, Eschwege E (1991) Insulin resistance, hypertriglyceridemia and cardiovascular risk: the Paris Prospective study. Diabet Metab 17:93–95

    Google Scholar 

  22. Freeman DJ, Norrie J, Sattar N et al (2001) Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation 103(3):357–362

    PubMed  Google Scholar 

  23. Gabor I, Spain M, Kalant N (1980) Composition of serum very low density and high density lipoprotein in diabetes. Clin Chem 26:1261–1265

    PubMed  Google Scholar 

  24. Galeano NF, Al-Haideri M, Keyserman F, Rumsey SC, Deckelbaum RJ (1998) Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity. J Lipid Res 39:1263–1273

    PubMed  Google Scholar 

  25. Gazzaruso C, Garzaniti A, Giordanetti S et al (2002) Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients. Diabetes Care 25:1418–1424

    PubMed  Google Scholar 

  26. Gianturco SH, Bradley WA (1991) A cellular basis for the atherogenicity of triglycerides-rich lipoproteins. In: Gotto AM, Paoletti R (eds) Triglycerides. The role in diabetes and atherosclerosis. Raven Press, New York. Atherosclerosis Reviews: 9–15

    Google Scholar 

  27. Ginsberg HN (1991) Lipoprotein ohysiology in nondiabetic and diabetic states. Relationship to atherosclerosis. Diabetes Care 14:839–850

    PubMed  Google Scholar 

  28. Golay A, Zech L, Shi MZ, Chiou Y-AM, Chen Y-DI (1985) High density lipoprotein turnover in noninsulin dependent diabetes mellitus. Diabetes 34:81

    PubMed  Google Scholar 

  29. Goldbourt U, Yaari S (1990) Cholesterol and coronary heart disease mortality: a 23-year follow-up study of 9902 men in Israel. Arteriosclerosis 10:512–519

    PubMed  Google Scholar 

  30. Gotto AM, Whitney E, Stein EA, Shapiro DR, Clear-field M, Weis S, Jou JY, Langendorfer A, Beere PA, Watson DJ, Downs JR, de Cani JS (2000) Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Circulation 101:477–484

    PubMed  Google Scholar 

  31. Haffner SM (1993) Lipoprotein(a) and diabetes. Diabetes Care 16:835–840

    PubMed  Google Scholar 

  32. Hanefeld M, Fischer S, Julius U et al (1996) Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39:1577–1583

    Article  PubMed  Google Scholar 

  33. Hanefeld M, Fischer S, Schulze J et al (1991) Therapeutic potentials of acarbose as a first-line drug in NIDDM insufficiently treated with diet alone. Diabetes Care 14(8):732–737

    PubMed  Google Scholar 

  34. Hanefeld M, Leonhardt W (1981) Das metabolische Syndrom. Dt Gesundh Wesen 36:545–551

    Google Scholar 

  35. Hanefeld M, Schmechel H, Julius U and the DIS group (1991) Five year incidence of coronary heart disease related to major risk factors and metabolic control in newly diagnosed non-insulin-dependent diabetes. The diabetes intervention study (DIS). Nutr Metab Cardiovasc Dis 1:135–140

    Google Scholar 

  36. Hanefeld M, Temelkova-Kurktschiev T (1995) Plasma lipids in diabetes. In: Schwartz CJ, Born GVR (eds) New horizons in diabetes mellitus and cardiovascular disease. Current Science, London, pp 89–96

    Google Scholar 

  37. Hanefeld M, Temelkova-Kurktschiev T (1997) Post-prandial state and atherosclerosis. Diabetic Medicine 14:S6–S11

    Article  PubMed  Google Scholar 

  38. Hanefeld M, Temelkova-Kurktschiev T, Köhler C (1997) Effect of oral antidiabetics and insulin on lipids and coronary heart disease in non-insulin-dependent diabetes mellitus. Annals of the New York Academy of Sciences (NYAS) 827:246–269

    Google Scholar 

  39. Hanefeld M (1990) Relationship between insulin and coronary heart disease. In: Standl E (ed) Perspectives of the hyperinsulinemia/insulin resistance syndrome in NIDDM. From pathophysiology to clinical implications. MMV, München, pp 70–73

    Google Scholar 

  40. Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, Ziegelasch HJ, Lindner J, the DIS Group (1996) Risk factors for myocardial infarction and death in newly detected NIDDM: The Diabetes Intervention Study, 11 years follow-up. Diabetologia 39:1577–1583

    Article  PubMed  Google Scholar 

  41. Hanefeld M, Temelkova-Kurktschiev T (2001) Diabetes mellitus und Dyslipoproteinämien. In: Schwandt P, Richter WO, Parhofer KG (Hrsg) Handbuch der Fettstoffwechselstörungen, 2. Aufl. Schattauer, Stuttgart, New York, S 239–256

    Google Scholar 

  42. Howard BV, Abbott WF, Beltz WF (1987) Integrated study of low density lipoprotein metabolism and very low density lipoprotein metabolism in non-insulin-dependent diabetes. Metabolism 36:870–877

    Article  PubMed  Google Scholar 

  43. Howard BV, Robbins DC, Sievers ML, Lee ET, Rhoades D, Devereux RB, Cowan LD, Gray RS, Welty TK, Go OT, Howard WJ (2000) LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart study. Arterioscler Thromb Vasc Biol 20:830–835

    PubMed  Google Scholar 

  44. Howard BV, Xiaoren P, Harper I, Foley JE, Cheung MC, Taskinen MR (1986) Effect of Sulfonylurea therapy on plasma lipids and high density lipoprotein composition in noninsulin dependent diabetes mellitus. Am J Med 79:78–85

    Google Scholar 

  45. Huttunen JK, Manninen V, Maenttaeri M, Koskinen P, Romo M, Tenkanen L, Heinonen OP, Frick MH (1991) The Helsinki Heart Study: Central findings and clinical implications. Ann Med 23:155–159

    PubMed  Google Scholar 

  46. Idzior-Walus B, Mattock MB, Solnica B et al (2001) Factors associated with plasma lipids and lipoproteins in type 2 diabetes mellitus: the EURODIAB IDDM Complications Study. Diabet Med 18(10):786–796

    Article  PubMed  Google Scholar 

  47. Isomaa B, Henricsson M, Almgren P, Tuomi T, Taskinen MR, Groop L (2001) The metabolic syndrome influences the risk of chronic complications in patients with type 2 diabetes. Diabetologia 44(9):1148–1154

    Article  PubMed  Google Scholar 

  48. Joslin EP (1927) Arteriosklerosis and diabetes. Ann Clin Med 5:1061–1079

    Google Scholar 

  49. Karhapää P, Malkki M, Laakso M (1994) Isolated low HDL cholesterol: an insulin-resistant state. Diabetes 43:411–417

    PubMed  Google Scholar 

  50. King A (2000) A comparison in a clinical setting of the efficacy and side effects of three thiazolidinediones. Diabetes Care 23:557

    Google Scholar 

  51. Kissebah AH, Alfarsi S, Evans DJ, Adams PW (1982) Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus. Diabetes 31:217–225

    PubMed  Google Scholar 

  52. Krolewski S, Kosinski EJ, Warram JH et al (1987) Magnitude and determinants of coronary heart artery disease in juvenile-onset, insulin dependent diabetes mellitus. Am J Cardiol 59:750–755

    Article  PubMed  Google Scholar 

  53. Laakso M (1996) Lipids and lipoproteins as risk factors for coronary heart disease in non-insulin-dependent diabetes mellitus. Ann Med 28(4):341–345

    PubMed  Google Scholar 

  54. Laakso M (1997) Dyslipidemia, morbidity and mortality in non-insulin-dependent diabetes mellitus. Lipoproteins and coronary heart disease in non-insulin-dependent diabetes mellitus. J Diabetes Complications 11(2):137–141

    Article  PubMed  Google Scholar 

  55. Lefebvre AM, Peinado-Onsurbe J, Leitersdorf I (1997) Regulation of lipoprotein metabolism by thiazolidinediones occurs through a distinct but complementary mechanism relative to fibrates. Arterioscler Thromb Vasc Biol 17:1756–1764

    PubMed  Google Scholar 

  56. Leonhardt W, Hanefeld M, Fischer S et al (1994) Efficacy of alpha-glucosidase inhibitors on lipids in NIDDM subjects with moderate hyperlipidaemia. Eur J Clin Invest 24(Suppl 3):45–49

    PubMed  Google Scholar 

  57. Hanefeld M, Cagatay M, Petrowitsch T, Neuser D, Petzinna D, Rupp M (2004) Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur Heart J 25:10–16

    Article  PubMed  Google Scholar 

  58. Olefsky JM, Farquhar JW, Reaven GM (1974) Reappraisal of the role of insulin in hypertriglyceridemia. Am J Med 57:551–560

    Article  PubMed  Google Scholar 

  59. Packard CJ, Munro A, Lorimer AR, Gotto AM, Shepherd J (1984) Metabolism of apolipoprotein B in large triglycerides-rich very low density lipoproteins of normal and hypertriglyceridemic subjects. J Clin Invest 74:2178–2192

    PubMed  Google Scholar 

  60. Taskinen MR, Kahri J, Koivisto V, Shepherd J, Packard C (1992) Metabolism of HDL apolipoprotein A-I and A-II in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:347–356

    Article  PubMed  Google Scholar 

  61. Reaven GM (2002) Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia. Diabetes Obes Metab (Suppl 1):13–18

    Google Scholar 

  62. Rizos E, Mikhailidis DP (2002) Are high-density lipoprotein and triglycerides levels important in secondary prevention: impressions from the BIP and VA-HIT trials. Int J Cardiol 82:199–207

    Article  PubMed  Google Scholar 

  63. Roheim PS, Asztalos BF (1995) Clinical significance of lipoprotein size and risk for coronary atherosclerosis. Clin Chem 41:147–152

    PubMed  Google Scholar 

  64. Salomaa VV, Tuomilehto J, Jauhiainen M et al (1992) Hypertriglyceridemia in different degrees of glucose intolerance in a Finnish population-based study. Diabetes Care 15:657–665

    PubMed  Google Scholar 

  65. Sane T, Taskinen MR (1993) Does familial hypertriglyceridemia predispose to NIDDM? Diabetes Care 16:1494–1501

    PubMed  Google Scholar 

  66. Shepherd J, Packard CJ (1991) Metabolic consequences of hypertriglyceridemia. In: Gotto AM, Paopletti R (eds) Atherosclerosis Reviews, vol. 22. Raven Press, New York, pp 1–8

    Google Scholar 

  67. Sniderman AD, Lamarche B, Tilley J et al (2002) Hypertriglyceridemic HyperapoB in type 2 diabetes. Diabetes Care 25:579–582

    PubMed  Google Scholar 

  68. Stamler J, Vaccaro O, Neaton J et al for the Multiple Risk Factor Intervention Trial Research Group (1993) Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trials. Diabetes Care 1993:434–449

    Google Scholar 

  69. Steinbrecher UP, Witztum IL (1984) Glycosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes 33:130–134

    PubMed  Google Scholar 

  70. Stern MP, Haffner SM (1991) Dyslipidemia in type II diabetes: implications for therapeutic intervention. Diabetes Care 14:1144–1159

    PubMed  Google Scholar 

  71. Tan MH (2000) How pioglitazone affects glucose and lipid metabolism. Exp Clin Endocrinol Diabetes 108(Suppl 2):224–233

    Google Scholar 

  72. Taskinen MR (1992) Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes 41(Suppl 2):12–17

    Google Scholar 

  73. Taskinen MR, Beltz WF, Harper I, Fields RM, Schonfeld G, Grundy SM, Howard BV (1986) The effects of noninsulin-dependent diabetes mellitus on VLDL trilyceride and VLDL apo B metabolism: studies before and after Sulfonylurea therapy. Diabetes 35:1268–1277

    PubMed  Google Scholar 

  74. Temelkova-Kurktschiev T, Hanefeld M, Leonhardt W (1997) Small dense low-density lipoprotein (LDL) in non-insulin-dependent diabetes mellitus (NIDDM). Impact of hypertriglyceridemia. Annals New York Academy of Sciences 827:279–286

    Google Scholar 

  75. Temelkova-Kurktschiev T, Köhler C, Schaper F et al (1998) Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in nondiabetic individuals. Diabetologia 41:706–712

    PubMed  Google Scholar 

  76. Temelkova-Kurktschiev T, Köhler C, Schaper F et al (1999) Increased intima-media thickness in newly detected type-2-diabetes: risk factors for it. Diabetes Care 22:333–338

    PubMed  Google Scholar 

  77. Temelkova-Kurktschiev T, Hanefeld M (2004) The lipid triad in type 2 diabetes — prevalence and relevance of hypertriglyceridemia/low high-density lipoprotein syndrome in type 2 diabetes. Exp Clin Endocrinol Diabetes 112(2)75–79

    Article  PubMed  Google Scholar 

  78. The BIP Study Group (2000) Secondary prevention by raising HDL-C and reducing triglycerides in patients with coronary artery disease. The Bezafibrate Infarction Prevention (BIP) Study. Circulation 102:21–27

    Google Scholar 

  79. The DCCT Research Group (1992) Lipid and lipoprotein levels in patients with IDDM: diabetes control and complications trial experience. Diabetes Care 15:886–894

    Google Scholar 

  80. Toyota Y, Yamamura T, Miyake Y, Yamamoto A (1999) Low density lipoprotein (LDL) binding affinity for the LDL receptor in hyperlipoproteinemia. Atherosclerosis 147(1):77–86

    Article  PubMed  Google Scholar 

  81. Tripathy D, Carlsson M, Almgren P (2000) Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes 49(6):975–980

    PubMed  Google Scholar 

  82. UKPDS Group (1998) Intensive blood control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854–865

    Google Scholar 

  83. UKPDS Group (1998) Intensive blood control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853

    Google Scholar 

  84. West KM, Ahuja MMS, Bennett PH (1983) The role of circulating glucose and triglyceride concentrations and their interactins with other „risk factors“ as determinants of arterial disease in nine diabetic population samples from the WHO Multinational Study. Diabetes Care 6:361–369

    PubMed  Google Scholar 

  85. Winocour UP, Currington PN, Ishola M et al (1986) Lipoprotein abnormalities in insulin-dependent diabetes mellitus. Lancet I:1176–1178

    Google Scholar 

  86. Yoshino G, Hirano T, Kazumi T (2002) Atherogenic lipoproteins and diabetes mellitus. J Diabetes Complications 16(1):29–34

    Article  PubMed  Google Scholar 

Download references

Authors
  1. M. Hanefeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Temelkova-Kurktschiev
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Klinik III Herzzentrum, Universitätskrankenhaus Eppendorf, Martinistraße 52, 20246, Hamburg

    Thomas Meinertz

  2. Deutsches Diabetes-Zentrum, Leibnitz-Institut an der Heinrich-Heine-Universität, Auf’m Hennekamp 65, 40225, Düsseldorf

    Peter Rösen  & Dan Ziegler  & 

  3. Deutsches Herzzentrum München Klinik für Herz- und Kreislauferkrankungen, Lazarettstraße 36, 80636, München

    Albert Schömig

  4. Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Georgstraße 11, 32545, Bad Oeynhausen

    Diethelm Tschöpe

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Steinkopff Verlag Darmstadt

About this chapter

Cite this chapter

Hanefeld, M., Temelkova-Kurktschiev, T. (2005). Lipide. In: Meinertz, T., Rösen, P., Ziegler, D., Schömig, A., Tschöpe, D. (eds) Diabetes und Herz. Steinkopff. https://doi.org/10.1007/3-7985-1531-X_2

Download citation

  • DOI: https://doi.org/10.1007/3-7985-1531-X_2

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-7985-1382-2

  • Online ISBN: 978-3-7985-1531-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation